The impact of disease-drug interactions on drug development and clinical practice

被引:5
|
作者
Cai, Hualin [1 ,2 ]
Chen, Xia [3 ,4 ]
机构
[1] Cent South Univ, Dept Pharm, Xiangya Hosp 2, Changsha, Peoples R China
[2] Cent South Univ, Inst Clin Pharm, Changsha, Peoples R China
[3] Capital Med Univ, Beijing Tiantan Hosp, Phase Unit 1, Beijing, Peoples R China
[4] Capital Med Univ, Beijing Tiantan Hosp, Natl Clin Res Ctr Neurol Dis, Beijing, Peoples R China
关键词
PHARMACOKINETICS;
D O I
10.1111/bcp.14469
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:712 / 714
页数:3
相关论文
共 50 条
  • [41] THE DRUG DEVELOPMENT PROCESS AND CLINICAL-PRACTICE
    SOMBERG, JC
    JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 30 (08): : 673 - 673
  • [42] Human Disease-Drug Network Based on Genomic Expression Profiles
    Hu, Guanghui
    Agarwal, Pankaj
    PLOS ONE, 2009, 4 (08):
  • [43] DRUG/DRUG AND DRUG/DISEASE INTERACTIONS AND DIABETES
    WHITE, JR
    CAMPBELL, RK
    DIABETES EDUCATOR, 1995, 21 (04): : 283 - &
  • [44] Is this the drug or dose for you? Impact and consideration of ethnic factors in global drug development, regulatory review, and clinical practice
    Huang, S-M
    Temple, R.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 84 (03) : 287 - 294
  • [45] DRUG DISEASE IN CLINICAL PRACTICE OF INFECTIOUS MALADIES
    BILIBIN, AF
    GRACHEVA, NM
    SOVETSKAYA MEDITSINA, 1974, (07): : 3 - 10
  • [46] Feature Engineering-Assisted Drug Repurposing on Disease-Drug Transcriptome Profiles in Gastric Cancer
    Kirboga, Kevser Kubra
    Rudrapal, Mithun
    ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES, 2024, 22 (04) : 181 - 191
  • [47] Why Innovation in Inflammatory Bowel Disease Drug Development Will Impact Your Practice
    Sandborn, William J.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2011, 9 (03) : 211 - 213
  • [48] Real clinical impact of drug-drug interactions of immunosuppressants in transplant patients
    Isabel Gago-Sanchez, Ana
    Font, Pilar
    Cardenas, Manuel
    Dolores Aumente, Maria
    Ramon Del Prado, Jose
    Angel Calleja, Miguel
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2021, 9 (06):
  • [49] The Development of Practice Recommendations for Drug-Disease Interactions by Literature Review and Expert Opinion
    van Tongeren, Justine M. Z.
    Harkes-Idzinga, S. Froukje
    van der Sijs, Heleen
    Atiqi, Roya
    van den Bemt, Bart J. F.
    Draijer, L. Willem
    Hiel, Deline
    Kerremans, Adrian
    Kremers, Bart
    de Leeuw, Marc
    Olthoff, Marleen V.
    Pham, T. Kim-Loan
    Valentijn-Robertz, Ricky
    Tsoi, Kayan
    Wichers, Iris
    de Wit, Maaike
    Borgsteede, Sander D.
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [50] Clinical implications from drug-drug and drug-disease interactions in older people
    Gnjidic, Danijela
    Johnell, Kristina
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2013, 40 (05) : 320 - 325